SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031478
Filing Date
2024-08-13
Accepted
2024-08-13 09:20:23
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 709078
2 ex10-4.htm EX-10.4 54274
3 ex10-5.htm EX-10.5 857257
4 ex10-6.htm EX-10.6 129749
5 ex31-1.htm EX-31.1 11996
6 ex32-1.htm EX-32.1 3894
7 ex10-4_002.jpg GRAPHIC 1400081
  Complete submission text file 0001493152-24-031478.txt   6807847

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE pulm-20240630.xsd EX-101.SCH 34853
9 XBRL CALCULATION FILE pulm-20240630_cal.xml EX-101.CAL 48817
10 XBRL DEFINITION FILE pulm-20240630_def.xml EX-101.DEF 135972
11 XBRL LABEL FILE pulm-20240630_lab.xml EX-101.LAB 267954
12 XBRL PRESENTATION FILE pulm-20240630_pre.xml EX-101.PRE 202425
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 474016
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 241199088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)